Life Science Innovation Northwest 2018
Impel co-founder and CSO, Dr. John Hoekman, presented today at 11:00 AM on a panel discussing, “What’s New in Alzheimer’s and Other Neurodegenerative Diseases?” at Life Science Innovation Northwest 2018 in Seattle, WA. The panel was moderated by Dr. Adrian Hobden, President & CEO of CereSpir. Dr. John Hoekman was joined by Dr. Leen Kawas, President & CEO of M3 Biotechnology. The topic was described by Life Science Washington as one of passionate discourse:
Alzheimer’s disease is the sixth leading cause of death in the U.S. and remains one of the biggest puzzles in the medical world. This devastating disease impacts millions of people across the globe. To date, efforts to address not only the symptoms but the root cause of the disease have been in vain with countless failures in the clinic. What research and developments are on the horizon to combat Alzheimer’s and other neurodegenerative diseases? This question evokes myriad answers and passionate discourse by researchers.
For more information, visit the event webpage here.